Accéder au contenu
MilliporeSigma

87368-M

Tétrahydrofurane

≥99.9%, ACS reagent, contains ~0.025% 2, 6-di-tert-butyl-4-methylphenol as stabilizer, 250 ppm BHT as inhibitor, suitable for solid phase extraction (SPE), reag. Ph. Eur.

Synonyme(s) :

Oxolane, Oxyde de butylène, Oxyde de tétraméthylène

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement

Changer de vue

A propos de cet article

Formule empirique (notation de Hill) :
C4H8O
Numéro CAS:
Poids moléculaire :
72.11
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12352005
EC Number:
203-726-8
MDL number:
Beilstein/REAXYS Number:
102391
Assay:
≥99.9%
Technique(s):
solid phase extraction (SPE): suitable
Bp:
65-67 °C (lit.)
Vapor pressure:
114 mmHg ( 15 °C), 143 mmHg ( 20 °C)
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider


Nom du produit

Tétrahydrofurane, contains 250 ppm BHT as inhibitor, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99.9%

Quality Level

agency

reag. Ph. Eur.

vapor density

2.5 (vs air)

vapor pressure

114 mmHg ( 15 °C), 143 mmHg ( 20 °C)

grade

ACS reagent, puriss. p.a.

assay

≥99.9%

form

liquid

autoignition temp.

610 °F

contains

250 ppm BHT as inhibitor, ~0.025% 2,6-di-tert-butyl-4-methylphenol as stabilizer

expl. lim.

1.8-11.8 %

technique(s)

solid phase extraction (SPE): suitable

impurities

≤0.001% free acid (as CH3COOH), ≤0.005% peroxides (as H2O2), ≤0.05% water

evapn. residue

≤0.001%

refractive index

n20/D 1.407

pH

~7

bp

65-67 °C (lit.)

mp

−108 °C (lit.)

density

0.887 g/mL at 20 °C, 0.889 g/mL at 25 °C (lit.)

SMILES string

C1CCOC1

cation traces

Al: ≤0.5 mg/kg, B: ≤0.02 mg/kg, Ba: ≤0.1 mg/kg, Bi: ≤0.1 mg/kg, Ca: ≤0.5 mg/kg, Cd: ≤0.05 mg/kg, Co: ≤0.02 mg/kg, Cr: ≤0.02 mg/kg, Cu: ≤0.02 mg/kg, Fe: ≤0.1 mg/kg, K: ≤0.5 mg/kg, Li: ≤0.1 mg/kg, Mg: ≤0.1 mg/kg, Mn: ≤0.02 mg/kg, Mo: ≤0.1 mg/kg, Na: ≤0.5 mg/kg, Ni: ≤0.02 mg/kg, Pb: ≤0.1 mg/kg, Sn: ≤0.1 mg/kg, Sr: ≤0.1 mg/kg, Zn: ≤0.1 mg/kg

InChI

1S/C4H8O/c1-2-4-5-3-1/h1-4H2

InChI key

WYURNTSHIVDZCO-UHFFFAOYSA-N

General description

The product is tetrahydrofuran (THF) and it contains 250ppm BHT (Butylated hydroxytoluene) as an inhibitor. THF is widely employed as a solvent. It constitutes the key fragment of various natural products (polyether antibiotics). THF forms double hydrate with hydrogen sulfide. Crystal structure of this double hydrate has been investigated by three-dimensional single-crystal studies. Butane-1,4-diol is formed as an intermediate during the synthesis of THF. Hot THF is useful for the dissolution of polyvinylidene chloride (PVDV).

Application

Tetrahydrofuran has been used as a solvent for the preparation of sol-gel solution for coating solid phase microextraction (SPME) fibers in a study.

It may be used for the dissolution of poly-ε-caprolactone (PCL) and 1,3-diaminopentane, during the preparation of poly-ε-caprolactone (PCL)-hydroxyapatite (HA) scaffolds and acrylate-terminated poly(5-amino-1-pentanol-co-1,4-butanediol diacrylate) (C32)- 1,3-diaminopentane (117) polymer, respectively.

Analysis Note

miscible with water and ethanol (96%) pass

Other Notes

Sales restrictions may apply


Still not finding the right product?

Explore all of our products under Tétrahydrofurane


signalword

Danger

supp_hazards

Classe de stockage

3 - Flammable liquids

flash_point_f

1.4 °F - closed cup

flash_point_c

-17.00 °C - closed cup

Hazard Classifications

Acute Tox. 4 Oral - Carc. 2 - Eye Dam. 1 - Flam. Liq. 2 - STOT SE 3

target_organs

Central nervous system, Respiratory system



Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents



Todd J Harris et al.
Biomaterials, 31(5), 998-1006 (2009-10-24)
The use of biomaterials for gene delivery can potentially avoid many of the safety concerns with viral gene delivery. However, the efficacy of polymeric gene delivery methods is low, particularly in vivo. One significant concern is that the interior and